---
title: "BAIYUNSHAN PH: Third quarter net profit of 794 million yuan, a year-on-year increase of 30.28%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263047931.md"
description: "BAIYUNSHAN PH announced that the revenue for the third quarter was 19.771 billion yuan, a year-on-year increase of 9.74%; the net profit was 794 million yuan, a year-on-year increase of 30.28%. The revenue for the first three quarters was 61.606 billion yuan, a year-on-year increase of 4.31%; the net profit was 3.31 billion yuan, a year-on-year increase of 4.78%"
datetime: "2025-10-28T09:37:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263047931.md)
  - [en](https://longbridge.com/en/news/263047931.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263047931.md)
---

# BAIYUNSHAN PH: Third quarter net profit of 794 million yuan, a year-on-year increase of 30.28%

BAIYUNSHAN PH announced that the revenue for the third quarter was 19.771 billion yuan, a year-on-year increase of 9.74%; the net profit was 794 million yuan, a year-on-year increase of 30.28%. The revenue for the first three quarters was 61.606 billion yuan, a year-on-year increase of 4.31%; the net profit was 3.31 billion yuan, a year-on-year increase of 4.78%

### Related Stocks

- [600332.CN](https://longbridge.com/en/quote/600332.CN.md)
- [00874.HK](https://longbridge.com/en/quote/00874.HK.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Elron says Axonius tops $200 million ARR, doubles revenue in two years](https://longbridge.com/en/news/287069566.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Can the business model of operators launching AI token packages be viable?](https://longbridge.com/en/news/286700860.md)
- [Palm Launches The Onboard Suite: Real-Time Access to 125 Million Businesses Across 150,000 Jurisdictions](https://longbridge.com/en/news/287063783.md)